CoV-2, the virus that causes COVID-19, have come and gone in the five years the illness has circulated the globe, its array ...

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio. Headquartered in Switzerland, Windward Bio is a ...

Cryogenic Systems are expected to grow at a rate of 6.5% per year, reaching a peak in 2021. According to Future Market ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Looking for smart, simple tips to help keep you healthy? Your Health is a free, monthly e-newsletter from Johns Hopkins Medicine.

Pulmocide Ltd., (“the Company”), a late-stage biopharmaceutical company developing inhaled opelconazole for patients suffering from serious acute and chronic respiratory diseases, today announced that ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against XEC Centers for Disease Control reports XEC and KP.3.1.1 (previously disclosed as sus ...